04.04.2014 • NewsDede WillamsDuPonttrade secret theft

U.S. Appeals Court Overturns $920 Million DuPont Award

A U.S. federal appeals court has overturned a 2011 jury decision awarding $920 million in damages to DuPont in a trade secrets lawsuit involving high-strength synthetic fibers used in products such as Kevlar body bullet-proof vests.

The case has been sent back to a district court in Virginia for further proceedings under a different trial judge.

In the verdict against South Korea's Kolon Industries dating from September 2011, the appeals court said the judge had abused his discretion and prejudiced the Korean company in granting a pretrial motion by DuPont, thus excluding evidence to Kolon's defense.

The same jury later found that Kolon had misappropriated 149 DuPont trade secrets relating to the latter's Kevlar para-aramid fiber, used to make tires, fiber-optic cables and body armor.

The appeals court said it was ruling "with reluctance," noting that Kolon and five executives were criminally charged in August 2012 with trade secret theft, after the FBI obtained what the court called "compelling evidence of Kolon's misconduct"

DuPont expressed disappointment at the decision and said it will continue to "vigorously pursue" Kolon to hold the company accountable.

Lawyers for the Korean company told the news agency Reuters, "DuPont has for decades published details about Kevlar in hundreds and hundreds of publicly available patents. A significant part of our defense is to be able to show that."

DuPont began the litigation in February 2009, claiming that Michael Mitchell, a 24-year veteran of the company, had taken proprietary information about Kevlar when he left in 2006 to start his own fibers business and later shared it with Kolon.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.